(Q79311532)
Statements
A motilin agonist, erythromycin, decreases circulating growth hormone levels in normal subjects but not in diabetic subjects (English)
Masaharu Uemoto
Yoshio Komatsu
Yoshiko Sato
1 November 2006
scientific article published on 01 November 2006